NDC product
AXIV Sinus Severe Mucus
NDC 82706-020 · VIVUNT PHARMA LLC
Key facts
| Product NDC | 82706-020 |
|---|---|
| Proprietary name | AXIV Sinus Severe Mucus |
| Nonproprietary name | Acetaminophen, Guaifenesin, Phenylephrine Hydrocloride |
| Substances | PHENYLEPHRINE HYDROCHLORIDE, GUAIFENESIN, ACETAMINOPHEN |
| Dosage form | CAPSULE, LIQUID FILLED |
| Route | ORAL |
| Labeler | VIVUNT PHARMA LLC |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC] |
| Marketing start | Mar 8, 2024 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: